The Effect of proteolysis-targeting chimera (PROTAC) of EZH2 on high grade Serous ovarian Carcinoma.

被引：0
|
作者：
Hachijo, Ryuta [1 ]
Sone, Kenbun [1 ]
Jonouchi, Yuri [1 ]
Ishizaka, Aya [1 ]
Suzuki, Eri [1 ]
Tsuchimochi, Saki [1 ]
Tanimoto, Saki [1 ]
Toyohara, Yusuke [1 ]
Honjo, Harunori [1 ]
Fukuda, Tomohiko [1 ]
Miyamoto, Yuichiro [1 ]
Mori, Mayuyo [1 ]
Oda, Katsutoshi [2 ]
Hirota, Yasushi [1 ]
Osuga, Yutaka [1 ]
机构：
[1] Univ Tokyo, Dept Obstet & Gynecol, Tokyo, Japan
[2] Univ Tokyo, Dept Clin Genom, Tokyo, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3205
引用
收藏
页码：1685 / 1685
页数：1
相关论文
共 50 条
  • [31] Transcriptional expression patterns of patient-derived tumorspheres predict outcomes in high-grade serous ovarian carcinoma.
    Boone, Jonathan David
    Johnston, Bobbi E.
    Cooper, Sara J.
    Straughn, John Michael
    Buchsbaum, Donald J.
    Arend, Rebecca Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] Identification of signal transduction pathway activity with potential clinical target in high-grade serous ovarian and tubal carcinoma.
    van der Ploeg, Phyllis
    van Lieshout, Laura A. M.
    Wesseling-Rozendaal, Yvonne J. W.
    Van de Stolpe, Anja
    Bosch, Steven L.
    Lentjes-Beer, Marjolein H. F. M.
    van Diest, Paul J.
    Vos, M. Caroline
    De Hullu, Joanne
    Bekkers, Ruud L. M.
    Piek, Jurgen M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Targeting endogenous and therapy-induced dependence on BCL-XL in high grade serous ovarian carcinoma
    Johnson, Lissah
    Qin, Xingping
    Fraser, Cameron
    Stover, Elizabeth
    Yang, Yang
    Zhou, Daohong
    Rueda, Bo
    Sarosiek, Kristopher
    CANCER RESEARCH, 2023, 83 (07)
  • [34] Reversing platinum resistance in high-grade serous ovarian carcinoma: targeting BRCA and the homologous recombination system
    Wiedemeyer, W. Ruprecht
    Beach, Jessica A.
    Karlan, Beth Y.
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [35] Overexpression of Enhancer of Zeste Homolog 2(EZH2) and Focal Adhesion Kinase (FAK) - In High Grade Endometrium Carcinoma
    Zhou, J.
    Bandyopadhyay, S.
    Chen, Z.
    Hussein, Y.
    Alosh, B.
    Jazaerly, T.
    Hayek, K.
    Ali-Fehmi, R.
    MODERN PATHOLOGY, 2012, 25 : 304A - 304A
  • [36] Overexpression of Enhancer of Zeste Homolog 2(EZH2) and Focal Adhesion Kinase (FAK) - In High Grade Endometrium Carcinoma
    Zhou, J.
    Bandyopadhyay, S.
    Chen, Z.
    Hussein, Y.
    Alosh, B.
    Jazaerly, T.
    Hayek, K.
    Ali-Fehmi, R.
    LABORATORY INVESTIGATION, 2012, 92 : 304A - 304A
  • [37] Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma
    Zhou, Jun
    Roh, Ju-Won
    Bandyopadhyay, Sudeshna
    Chen, Zhengming
    Munkarah, Adnan R.
    Hussein, Yaser
    Alosh, Baraa
    Jazaerly, Tarek
    Hayek, Kinda
    Semaan, Assaad
    Sood, Anil K.
    Ali-Fehmi, Rouba
    GYNECOLOGIC ONCOLOGY, 2013, 128 (02) : 344 - 348
  • [38] Does Subdividing High Grade Ovarian Serous Carcinoma into Silverberg Grade 2 and 3 Have Biologic Validity?
    Feeley, L.
    Mulligan, A. M.
    Yao, C.
    Chen, H.
    Gilks, B.
    Boutros, P.
    Clarke, B.
    LABORATORY INVESTIGATION, 2011, 91 : 245A - 245A
  • [39] Does Subdividing High Grade Ovarian Serous Carcinoma into Silverberg Grade 2 and 3 Have Biologic Validity?
    Feeley, L.
    Mulligan, A. M.
    Yao, C.
    Chen, H.
    Gilks, B.
    Boutros, P.
    Clarke, B.
    MODERN PATHOLOGY, 2011, 24 : 245A - 245A
  • [40] Defining the impact of Chromobox 2 on the immune tumor microenvironment of high grade serous ovarian carcinoma
    Brubaker, Lindsay
    Yamamoto, Tomomi
    Jordan, Kimberly
    Mitra, Siddhartha
    Bitler, Benjamin
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S62 - S63
12345